Vivos Therapeutics Inc
NASDAQ:VVOS
Cash Flow Statement
Cash Flow Statement
Vivos Therapeutics Inc
| Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||||
| Net Income |
(10)
|
(8)
|
(12)
|
(15)
|
(16)
|
(19)
|
(20)
|
(22)
|
(25)
|
(25)
|
(24)
|
(20)
|
(19)
|
(15)
|
(14)
|
(16)
|
(12)
|
(13)
|
(11)
|
(11)
|
(14)
|
(17)
|
|
| Depreciation & Amortization |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Stock-Based Compensation |
0
|
1
|
2
|
2
|
2
|
3
|
3
|
2
|
2
|
2
|
2
|
2
|
2
|
1
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Other Non-Cash Items |
3
|
2
|
6
|
7
|
6
|
7
|
4
|
3
|
3
|
3
|
2
|
0
|
1
|
(2)
|
(2)
|
1
|
(1)
|
1
|
1
|
1
|
1
|
1
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
|
| Change in Working Capital |
3
|
2
|
(0)
|
(2)
|
(3)
|
(4)
|
0
|
1
|
2
|
1
|
2
|
2
|
2
|
4
|
3
|
3
|
1
|
(2)
|
(3)
|
(4)
|
(2)
|
1
|
|
| Cash from Operating Activities |
(4)
N/A
|
(4)
+3%
|
(6)
-56%
|
(10)
-68%
|
(12)
-24%
|
(15)
-29%
|
(16)
-3%
|
(18)
-14%
|
(19)
-5%
|
(21)
-9%
|
(20)
+5%
|
(17)
+13%
|
(15)
+11%
|
(12)
+20%
|
(12)
+2%
|
(11)
+9%
|
(11)
-2%
|
(12)
-13%
|
(13)
-2%
|
(14)
-10%
|
(14)
-3%
|
(14)
+0%
|
|
| Investing Cash Flow | |||||||||||||||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Other Items |
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(5)
|
(5)
|
|
| Cash from Investing Activities |
0
N/A
|
0
+7%
|
(0)
N/A
|
(0)
-217%
|
(2)
-400%
|
(2)
-22%
|
(3)
-13%
|
(2)
+5%
|
(1)
+42%
|
(1)
+24%
|
(1)
+16%
|
(1)
-18%
|
(1)
+24%
|
(1)
-7%
|
(1)
+4%
|
(1)
+16%
|
(1)
+25%
|
(1)
-6%
|
(1)
-1%
|
(1)
+5%
|
(6)
-1 085%
|
(6)
+4%
|
|
| Financing Cash Flow | |||||||||||||||||||||||
| Net Issuance of Common Stock |
0
|
2
|
23
|
0
|
50
|
47
|
26
|
0
|
(1)
|
0
|
0
|
8
|
8
|
8
|
12
|
8
|
15
|
20
|
19
|
0
|
11
|
9
|
|
| Net Issuance of Debt |
4
|
2
|
1
|
1
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
9
|
|
| Other |
0
|
(0)
|
(0)
|
0
|
(2)
|
(2)
|
(2)
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(1)
|
|
| Cash from Financing Activities |
4
N/A
|
4
+3%
|
24
+501%
|
24
0%
|
47
+102%
|
45
-6%
|
24
-46%
|
24
+0%
|
(1)
N/A
|
0
N/A
|
0
N/A
|
7
N/A
|
7
N/A
|
7
N/A
|
11
+48%
|
7
-34%
|
15
+102%
|
19
+27%
|
18
-4%
|
14
-20%
|
18
+29%
|
17
-7%
|
|
| Change in Cash | |||||||||||||||||||||||
| Net Change in Cash |
0
N/A
|
0
+159%
|
18
+3 932%
|
14
-23%
|
34
+149%
|
27
-20%
|
6
-78%
|
4
-35%
|
(22)
N/A
|
(22)
-1%
|
(21)
+6%
|
(11)
+47%
|
(9)
+19%
|
(6)
+34%
|
(2)
+67%
|
(4)
-137%
|
3
N/A
|
6
+88%
|
5
-16%
|
(0)
N/A
|
(2)
-819%
|
(3)
-38%
|
|
| Free Cash Flow | |||||||||||||||||||||||
| Free Cash Flow |
(4)
N/A
|
(4)
+4%
|
(6)
-55%
|
(10)
-71%
|
(13)
-36%
|
(17)
-29%
|
(18)
-5%
|
(20)
-11%
|
(20)
-1%
|
(22)
-7%
|
(21)
+6%
|
(18)
+12%
|
(16)
+11%
|
(13)
+19%
|
(13)
+2%
|
(12)
+9%
|
(12)
0%
|
(13)
-12%
|
(13)
-2%
|
(15)
-9%
|
(16)
-8%
|
(15)
+2%
|
|